A pan-European collaborative network

CardioRNA COST Action CA17129 is a pan-European collaborative network of multidisciplinary researchers, clinicians and industrial partners which aims to accelerate the understanding of transcriptomics in cardiovascular disease (CVD) and to further translate experimental data into applications that can be used to improve personalised medicine in this field.

Opportunities for collaboration between stakeholders

CardioRNA aims to provide opportunities for collaboration between stakeholders from complementary backgrounds, enabling the functions of different RNAs and their interactions in the cardiovascular context to be deciphered more quickly and translated into clinical applications. This Action will result in grant proposals aimed at better understanding the role of the transcriptome in cardiovascular disease and translating the results into clinical applications, thereby promoting personalised medicine and addressing a current public health challenge.

COST Partner Countries

  1. Austria
  2. Hungary
  3. Serbia
  4. Belgium
  5. Ireland
  6. Slovakia
  7. Bosnia and Herzegovina
  8. Isreal
  9. Slovenia
  10. Croatia
  11. Italy
  12. Spain
  13. Cyprus
  14. Luxembourg
  15. Sweden
  16. Czech Republic
  17. Malta
  18. Switzerland
  19. Denmark
  20. Netherlands
  21. Turkey
  22. Finland>
  23. Norway
  24. United Kingdom
  25. France
  26. Poland
  27. Estonia
  28. Germany>
  29. Portugal
  30. Greece
  31. Romania

COST International Partner Countries

  1. Australia
  2. United States of America
  3. Singapore


COST Action partner countries

COST Partner countries - CA 17129


More info on EU-CardioRNA



Dr Yvan DEVAUX, Chair


Dr Emma ROBINSON, Science Communication Manager